The investment will reportedly be used to increase the company’s product line, using domestically made raw materials exclusively. So far CFPS has been active in Moscow predominantly; with the new funds it expects to expand in Russia’s regions and boost sales there.
According to Stanislav Goldberg, one of the project masterminds, CFPS’ Russian market share “tops 80% in a number of segments.”
Central Factory of Prepared Solutions was set up two years ago. RVC was a co-investor, with Israel’s Novamed providing technology to start with.
Source: http://marchmontnews.com/Finance-Business/Central-regions/21424-Moscow-and-federal-funds-invest-biosolutions-for-diagnostics-and-research.html